Hanmi offers 30 billion won share swap to Dong-A

Published: 2007-03-15 07:00:00

Updated: 2007-03-15 07:00:00

Hanmi Pharm Chairman Lim Sung-ki met Dong-A Pharmaceutical Chairman Kang Shin-ho on March 9 and suggested that the two exchange 30 billion won worth of shares in the two drug companies, according to Dong-A Pharm.

Lim suggested that he would support the senior Kang at a shareholders meeting at ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK